Contact
Please use this form to send email to PR contact of this press release:
CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree to merge in an all-stock transaction
TO:
Please use this form to send email to PR contact of this press release:
CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree to merge in an all-stock transaction
TO: